| Dr John M Hamill, MD | |
|
100 Hospital Dr, Athens, OH 45701-2301 | |
| (740) 594-5000 | |
| (740) 592-5402 |
| Full Name | Dr John M Hamill |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 37 Years |
| Location | 100 Hospital Dr, Athens, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861483703 | NPI | - | NPPES |
| 2032268 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 35056975 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Ohio Office Of Budget And Management State Accounting | 0143133181 | 100 |
| Hocking Valley Medical Group, Inc. | 0345238622 | 16 |
News Archive
Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine.
The expansion of Medicare included in a Senate compromise hailed as a breakthrough in the discussions of health care overhaul earlier this week is now encountering some friction.
Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.
Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.
› Verified 1 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine.
The expansion of Medicare included in a Senate compromise hailed as a breakthrough in the discussions of health care overhaul earlier this week is now encountering some friction.
Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.
Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.
› Verified 1 days ago
| Entity Name | State Of Ohio Office Of Budget And Management State Accounting |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023082716 PECOS PAC ID: 0143133181 Enrollment ID: O20031202000209 |
News Archive
Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine.
The expansion of Medicare included in a Senate compromise hailed as a breakthrough in the discussions of health care overhaul earlier this week is now encountering some friction.
Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.
Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.
› Verified 1 days ago
| Entity Name | Hocking Valley Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801994827 PECOS PAC ID: 0345238622 Enrollment ID: O20040505000146 |
News Archive
Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine.
The expansion of Medicare included in a Senate compromise hailed as a breakthrough in the discussions of health care overhaul earlier this week is now encountering some friction.
Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.
Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.
› Verified 1 days ago
| Entity Name | Ohio Psychiatric Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902359383 PECOS PAC ID: 1850689266 Enrollment ID: O20161017002698 |
News Archive
Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine.
The expansion of Medicare included in a Senate compromise hailed as a breakthrough in the discussions of health care overhaul earlier this week is now encountering some friction.
Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.
Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John M Hamill, MD 100 Hospital Dr, Athens, OH 45701-2301 Ph: (740) 594-5000 | Dr John M Hamill, MD 100 Hospital Dr, Athens, OH 45701-2301 Ph: (740) 594-5000 |
News Archive
Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine.
The expansion of Medicare included in a Senate compromise hailed as a breakthrough in the discussions of health care overhaul earlier this week is now encountering some friction.
Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.
Results from two significant Canadian studies underscore the growing scientific evidence of PEGETRON's positive outcomes in the treatment of chronic hepatitis C virus (HCV) infection. Canadian investigators across the country collaborated to generate and analyze clinical data from the Canadian PEGETRON POWeR (Prospective Optimal Weight-based Dosing Response) and REDIPEN programs, which were presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston on November 1, 2009.
› Verified 1 days ago
Mark F Mcgee, M. D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 90 Hospital Dr, Athens, OH 45701 Phone: 740-592-3091 Fax: 740-773-3985 | |
Sathya P Rajan, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 510 W Union St, Athens Va Out Patient Clinic, Athens, OH 45701 Phone: 740-593-7314 Fax: 740-594-2804 | |
Dr. James Diskin, DO Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 100 Hospital Dr, Athens, OH 45701 Phone: 740-274-4840 | |
Dr. William J Resch, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 90 Hospital Dr, Athens, OH 45701 Phone: 740-593-3682 Fax: 740-594-5642 | |
Gary Edward Cordingley, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Hospital Drive, Suite 360, Athens, OH 45701 Phone: 740-594-8147 Fax: 740-594-8148 | |
Leslie Mira Abromowitz, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 90 Hospital Dr, Athens, OH 45701 Phone: 740-592-3091 Fax: 740-773-3985 | |
Nathanael Oetoyo Sidharta, M. D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Dr, Athens, OH 45701 Phone: 740-589-4136 Fax: 740-594-7604 |